PLUS THERAPEUTICS, INC. — All Filings
1,002 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12G
10-12G/A
10-K
10-K/A
10-Q
10-Q/A
144
25-NSE
3
3/A
4
4/A
424B2
424B3
424B4
424B5
5
8-A12B
8-A12G
8-K
8-K/A
ARS
CERT
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEFR14A
DRS
EFFECT
FWP
NT 10-Q
POS AM
PRE 14A
PRER14A
REGDEX
RW
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SD
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-26-125195 | Mar 26, 2026 | Mar 20, 2026 |
| 8-K | 8-K | 0001193125-26-104291 | Mar 12, 2026 | Mar 11, 2026 |
| 10-K | 10-K | 0001193125-26-104258 | Mar 12, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-104218 | Mar 12, 2026 | — |
| RW | RW | 0001193125-26-096495 | Mar 6, 2026 | — |
| 4 | 4 | 0001193125-26-082607 | Feb 27, 2026 | Feb 25, 2026 |
| 4 | 4 | 0001193125-26-082584 | Feb 27, 2026 | Feb 25, 2026 |
| 8-K | 8-K | 0001193125-26-051379 | Feb 13, 2026 | Feb 9, 2026 |
| SCHEDULE 13G | — | 0001649553-26-000002 | Jan 22, 2026 | — |
| 8-K | 8-K | 0001193125-26-018675 | Jan 22, 2026 | — |
| 8-K | 8-K | 0001193125-26-015346 | Jan 16, 2026 | Jan 13, 2026 |
| 424B4 | 424B4 | 0001193125-26-012905 | Jan 14, 2026 | — |
| EFFECT | — | 9999999995-26-000164 | Jan 13, 2026 | — |
| S-1MEF | S-1MEF | 0001193125-26-012091 | Jan 13, 2026 | — |
| S-1 | S-1 | 0001193125-26-008922 | Jan 9, 2026 | — |
| 4 | 4 | 0001193125-26-000967 | Jan 2, 2026 | Jan 1, 2026 |
| 4 | 4 | 0001193125-26-000966 | Jan 2, 2026 | Jan 1, 2026 |
| DRS | — | 0001193125-25-294028 | Nov 25, 2025 | — |
| 8-K | 8-K | 0001193125-25-283935 | Nov 17, 2025 | — |
| 4 | 4 | 0001193125-25-265866 | Nov 5, 2025 | Nov 4, 2025 |
| 10-Q | 10-Q | 0001193125-25-258596 | Oct 30, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-258568 | Oct 30, 2025 | — |
| 8-K | 8-K | 0001193125-25-244275 | Oct 21, 2025 | Oct 16, 2025 |
| 4 | 4 | 0001193125-25-230296 | Oct 3, 2025 | Oct 1, 2025 |
| 4/A | 4/A | 0001193125-25-230292 | Oct 3, 2025 | Aug 13, 2025 |
| 4 | 4 | 0001193125-25-230291 | Oct 3, 2025 | Oct 1, 2025 |
| 4/A | 4/A | 0001193125-25-230288 | Oct 3, 2025 | Aug 13, 2025 |
| 8-K | 8-K | 0001193125-25-188075 | Aug 26, 2025 | — |
| 4 | 4 | 0000950170-25-111092 | Aug 25, 2025 | Aug 22, 2025 |
| S-8 | S-8 | 0001193125-25-186490 | Aug 22, 2025 | — |
| 4 | 4 | 0000950170-25-109414 | Aug 15, 2025 | Aug 13, 2025 |
| 4 | 4 | 0000950170-25-109413 | Aug 15, 2025 | Aug 13, 2025 |
| 4 | 4 | 0000950170-25-109412 | Aug 15, 2025 | Aug 13, 2025 |
| 4 | 4 | 0000950170-25-109411 | Aug 15, 2025 | Aug 13, 2025 |
| 4 | 4 | 0000950170-25-109410 | Aug 15, 2025 | Aug 13, 2025 |
| 4 | 4 | 0000950170-25-109409 | Aug 15, 2025 | Aug 13, 2025 |
| 4 | 4 | 0000950170-25-109408 | Aug 15, 2025 | Aug 13, 2025 |
| 424B3 | 424B3 | 0001193125-25-181897 | Aug 15, 2025 | — |
| 3 | 3 | 0000950170-25-109401 | Aug 15, 2025 | Apr 18, 2025 |
| EFFECT | — | 9999999995-25-002625 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001079973-25-001307 | Aug 14, 2025 | — |
| 8-K | 8-K | 0001193125-25-180814 | Aug 14, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-108874 | Aug 14, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-108854 | Aug 14, 2025 | — |
| 8-K | 8-K | 0001193125-25-179382 | Aug 13, 2025 | — |
| CORRESP | — | 0001193125-25-179175 | Aug 12, 2025 | — |
| 8-K | 8-K | 0001193125-25-179012 | Aug 12, 2025 | Aug 7, 2025 |
| S-1 | S-1 | 0001193125-25-178940 | Aug 12, 2025 | — |
| UPLOAD | — | 0000000000-25-008211 | Aug 5, 2025 | — |
| DRS | — | 0000950123-25-006916 | Aug 4, 2025 | — |